Atlas Trials

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

Clinical trial NCT04987229 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT04987229
Sponsor
Alkermes, Inc.
Status
ENROLLING_BY_INVITATION
Phase
Phase 3
Study type
INTERVENTIONAL
Bipolar I DisorderSchizophrenia
Start date
2021-10-22
Primary completion
2027-09-01
Enrollment
236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.